Karl-Erik Andersson
121 – 130 of 167
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Erectile physiological and pathophysiological pathways involved in erectile dysfunction.
(
- Contribution to journal › Article
-
Mark
Third International Conference on the Management of Erectile Dysfunction: Linking pathophysiology and therapeutic response
(
- Contribution to journal › Debate/Note/Editorial
- 2002
-
Mark
Overactive bladder--pharmacological aspects.
(
- Contribution to journal › Article
-
Mark
Effects of beta(3)-adrenoceptor stimulation on prostaglandin E-2-induced bladder hyperactivity and on the cardiovascular system in conscious rats
(
- Contribution to journal › Article
-
Mark
Effects of NAD-299, a new, highly selective 5-HT(1A) receptor antagonist, on bladder function in rats.
(
- Contribution to journal › Article
-
Mark
New directions for erectile dysfunction therapies.
(
- Contribution to journal › Article
-
Mark
Overview consensus statement
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Enhancement of apomorphine-induced penile erection in the rat by a selective alpha(1D)-adrenoceptor antagonist.
(
- Contribution to journal › Article
-
Mark
Future drugs for the treatment of benign prostatic hyperplasia.
(
- Contribution to journal › Article
-
Mark
Effects of selective beta 2 and beta 3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats
(
- Contribution to journal › Article